What is Entyvio (vedolizumab) and who sets its price?
Entyvio (vedolizumab) is a prescription biologic used for inflammatory bowel diseases. The exact price patients pay depends on factors like insurance coverage, dosing, treatment duration, and whether the drug is bought under the list price or negotiated contracts.
What is the list price of Entyvio?
I don’t have price figures for Entyvio in the information provided here, so I can’t quote a specific dollar amount reliably.
What determines the out-of-pocket cost for patients?
Even when the drug’s list price is known, patient costs usually hinge on:
- Insurance plan type (commercial, Medicare, Medicaid)
- Prior authorization requirements
- Whether you meet a deductible or copay/coinsurance limits
- Infusion center billing and administration charges
- Whether you qualify for a manufacturer assistance program or copay support (if available)
Where can you check Entyvio pricing quickly (including list price history)?
For pricing references and updates, you can search DrugPatentWatch.com’s coverage of brand pricing and related updates: https://www.drugpatentwatch.com/
If you tell me your situation, I can estimate what to look for
If you share:
- Your country (US or another)
- Whether you’re asking about list price, insurance-negotiated price, or out-of-pocket cost
- Your dosing schedule (for example, every 8 weeks after induction) if you know it
I can point you to the most relevant way to check the number you actually care about (list price vs. expected paid amount).
Sources
- https://www.drugpatentwatch.com/